SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis
7 references·0 citing·32 second hop
Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis (1999)Population based cost utility study of in…Value and cost‐effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window‐phase human immunodeficiency virus type 1 infections (1997)Value and cost‐effectiveness …Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis (1997)Comparison of a generic to di…A social tariff for EuroQol: results from a UK general population survey (1995)A social tariff for EuroQol: …Qaly league tables: Handle with care (1993)Qaly league tables: Handle wi…How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)How attractive does a new tec…EuroQol - a new facility for the measurement of health-related quality of life (1990)EuroQol - a new facility for …Economics, medicine, and health care (1986)Economics, medicine, and heal…A methodological framework for assessing health indices (1985)Measurement of health state utilities for economic appraisal (1986)Meta-Analyses of Randomized Controlled Trials (1987)Costs, effects and C/E‐ratios alongside a clinical trial (1994)A study of the quality of life and cost-utility of renal transplantation (1996)Multiattribute Utility Function for a Comprehensive Health Status Classification System (1996)Economics of coronary artery bypass grafting. (1985)Utilities and Quality-Adjusted Life Years (1989)Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. (2003)HTA 101 INTRODUCTION TO HEALTH TECHNOLOGY ASSESSMENT (2004)Public views on principles for health care priority setting: Findings of a European cross-country study using Q methodology (2014)Coefficient Alpha and the Internal Structure of Tests (1951)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)The MOS 36-ltem Short-Form Health Survey (SF-36) (1992)The SF-36 in multiple sclerosis: why basic assumptions must be tested (2001)[Evaluation of the quality of life]. (2002)Use of the SF-36 and other health-related quality of life measures to assess persons with disabilities (2002)Clinical Decision Analysis (1980)The Markov Process in Medical Prognosis (1983)The Risk of Transfusion-Transmitted Viral Infections (1996)Equity and the economic evaluation of healthcare (2001)[Risk of transfusional-transmitted infections]. (2002)Uses and sources of data on long-term survival after blood transfusion (2003)A review of the use of health status measures in economic evaluation. (1999)A Comparison of United Kingdom and Spanish General Population Time Trade-off Values for EQ-5D Health States (2001)Estimating an EQ‐5D population value set: the case of Japan (2002)Cost-utility in practice: A policy maker's guide to the state of the art (1992)Chapter 2 An overview of the normative economics of the health sector (2000)Valuing the benefits and costs of health care programmes: where's the ‘extra’ in extra-welfarism? (2003)EuroQol: the current state of play (1996)Modeling Valuations for EuroQol Health States (1997)EQ-SD: a measure of health status from the EuroQol Group (2001)
this work references cited by second hop

References

  • 1990EuroQol - a new facility for the measurement of health-related quality of life15,736 cited
  • 1992How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.1,581 cited
  • 1995A social tariff for EuroQol: results from a UK general population survey611 cited
  • 1993Qaly league tables: Handle with care204 cited
  • 1986Economics, medicine, and health care200 cited
  • 1997Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis153 cited
  • 1997Value and cost‐effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window‐phase human immunodeficiency virus type 1 infections32 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work